Potensi Pemeriksaan PA dalam Pemeriksaan Tahap Lanjutan pada Terapi Kanker Paru

Lung cancer which found mostly in men has been one of problematic diseases in the world as well as in Indonesia. It is currently stated as a disease with the highest death rate. Pollutants and smoking habits are two main causes of lung cancer that researchers have found. The world’s improvement in the study of carcinogenesis and molecular protein bring impacts in the study of lung cancer. Research findings of protein inhibitor to carcinogenesis and new proteins become defiances to the existing therapy that convey great challenges, yet bring a new hope in giving specific therapy through molecular approach. This approach closely relates to genomic projects and has more moderate form of derivation in anatomy pathology examination. Examination technology advance in several researches shows little hopes in giving lung cancer patients’ longer lifespan which are not completely satifsying. This study aims to give broader insights and an identifier to a more sustain advanced anatomy pathology in determining targeted theraphy and in decision making on giving chemoteraphy medicine. Therefore, chemotheraphy medicines/treatments will not merely be based only on clinical reasons, but also use more molecular protein approach individually. Keyword: Lung cancer, theraphy, molecular protein